Loading...
Broadly neutralizing antibodies for HIV-1: efficacies, challenges and opportunities
Combination antiretroviral therapy (cART) is effective but not curative, and no successful vaccine is currently available for human immunodeficiency virus-1 (HIV-1). Broadly neutralizing antibodies (bNAbs) provide a new approach to HIV-1 prevention and treatment, and these promising candidates advan...
Saved in:
| Published in: | Emerg Microbes Infect |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Taylor & Francis
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7040474/ https://ncbi.nlm.nih.gov/pubmed/31985356 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/22221751.2020.1713707 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|